Imaging of Liver and Spleen Morphology

In most nuclear medicine departments throughout the world, gamma cameras have completely replaced rectilinear scanners. A large field of view gamma camera with a single or dual head, fitted with a low-energy, parallel hole, all-purpose collimator, is generally chosen for most planar studies using technetium-99m-labeled agents. The main advantage of the dual-head gamma camera is patient convenience, where the data collection time is reduced by one-half as it allows simultaneous anterior and posterior image acquisition. The reduction in imaging time often improves the spatial resolution because of less patient movement during data collection. A triple-head gamma camera, when available, is preferred for SPECT images. The gamma camera image acquisition parameters are identical for both the liver and spleen.

[1]  M. Mirza,et al.  Letter: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives. , 1976, Annals of internal medicine.

[2]  Wiklund Ra,et al.  First of two parts , 1997 .

[3]  L. Krulich,et al.  Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. , 1968, Endocrinology.

[4]  R. Jeffrey,et al.  Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. , 1993, Radiology.

[5]  D. Marks,et al.  Ultrasonic features and radionuclide correlation in liver cell adenoma and focal nodular hyperlasia. , 1980, Radiology.

[6]  P. Sheedy,et al.  Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. , 1985, Radiology.

[7]  S. Reichlin Somatostatin. , 1983, The New England journal of medicine.

[8]  J. Selby Nuclear Medicine Annual, 1995 , 1996 .

[9]  G. Glazer,et al.  The varied appearances of hepatic cavernous hemangiomas with sonography, computed tomography, magnetic resonance imaging and scintigraphy. , 1987, Radiographics : a review publication of the Radiological Society of North America, Inc.

[10]  Milton J. Finegold Tumors of the Liver , 1994, Seminars in liver disease.

[11]  P. Hoffer,et al.  The use of inspiration-expiration scintiphotographs to determine the intrinsic or extrinsic nature of liver defects. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  D. Venzon,et al.  Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study , 1996, Annals of Internal Medicine.

[13]  A. Gottschalk,et al.  Diagnostic significance of the relative uptake of liver compared with spleen in 99mTc-sulfur colloid scintiphotography. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  Eva Forssell-Aronsson,et al.  Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  M. Thelen,et al.  Focal nodular hyperplasia of the liver as established by 99mTc sulfur colloid and HIDA scintigraphy. , 1980, Radiology.

[16]  H. Wagner,et al.  DIAGNOSTIC VALUE OF SCINTILLATION SCANNING OF THE LIVER. , 1965, Archives of internal medicine.

[17]  T. Shawker,et al.  A Prospective Analysis of Laboratory Tests and Imaging Studies To Detect Hepatic Lesions , 1982, Annals of surgery.

[18]  R. Howman-Giles,et al.  TI-201 positive, Ga-67 negative hepatoblastoma : A case report of a 12-year-old boy , 1997 .

[19]  S. Reichlin Somatostatin (First of two parts) , 1983 .

[20]  A. Megibow,et al.  Observations on the growth of renal neoplasms. , 1990, Radiology.

[21]  K. Endo,et al.  Radiation dosimetry for indium-111-pentetreotide. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  W. Blahd,et al.  Diagnosis of hepatic hemangioma using multiple-radionuclide and ultrasound techniques. , 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  J. Doppman,et al.  Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. , 1997, Gastroenterology.

[24]  N. Shuke,et al.  Focal nodular hyperplasia of the liver: scintigraphic demonstration using three hepatic imaging agents. , 1999, Clinical nuclear medicine.

[25]  D. Becker,et al.  Evaluation of spleen size during routine liver imaging with 99mTc and the scintillation camera. , 1970, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  J. Doppman,et al.  Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  S. Sherlock,et al.  Diseases of the Liver and Biliary System , 1955 .

[28]  K. Suga,et al.  Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuclide imaging. , 1997, Clinical nuclear medicine.

[29]  A. Rahmouni,et al.  The hot spot hepatobiliary scan in focal nodular hyperplasia. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  A. Zucker CURABILITY OF BREAST CANCER , 1975, The Lancet.

[31]  A. Megibow,et al.  Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. , 1990, Radiology.

[32]  E. P. Krenning,et al.  Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients , 1993, European Journal of Nuclear Medicine.

[33]  E. P. Krenning,et al.  LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN , 1989, The Lancet.

[34]  A. Maurer,et al.  Hepatic cavernous hemangioma: diagnosis with 99mTc-labeled red cells and single-photon emission CT. , 1987, AJR. American journal of roentgenology.

[35]  M. Sinanan,et al.  Management of cavernous hemangioma of the liver. , 1989, American journal of surgery.

[36]  J. Quinn Nuclear Medicine in Gastroenterology , 1972 .

[37]  K. Ishak,et al.  Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlation. , 1987, AJR. American journal of roentgenology.

[38]  M. Salvatore,et al.  Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. , 1997, The New England journal of medicine.

[39]  T. Waldmann,et al.  α-Fetoprotein in Nonneoplastic Hepatic Disorders , 1975 .

[40]  T. Mcgarrity,et al.  An analysis of imaging studies and liver function tests to detect hepatic neoplasia , 1987, Digestive Diseases and Sciences.

[41]  R. Peters,et al.  Tumors of the Liver and Intrahepatic Bile Ducts , 1990 .

[42]  J. Fletcher,et al.  Xenon-133 accumulation in hepatic steatosis. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  G. Denardo,et al.  Hepatic scintiangiographic patterns. , 1974, Radiology.

[44]  L. Kvols,et al.  Distribution of somatostatin receptors in normal and tumor tissue. , 1990, Metabolism: clinical and experimental.

[45]  B. J. McConnell,et al.  133xe uptake in focal hepatic fat accumulation: CT correlation. , 1982, AJR. American journal of roentgenology.

[46]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[47]  D. Knowles,et al.  Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. , 1976, Human pathology.

[48]  E P Krenning,et al.  Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  K. Ishak,et al.  Benign tumors of the liver. , 1975, The Medical clinics of North America.

[50]  Possible association between benign hepatomas and oral contraceptives. , 1973 .

[51]  E. McClees,et al.  Screening for Diffuse and Focal Liver Disease: The Case for Hepatic Scintigraphy , 1984, Journal of clinical ultrasound : JCU.

[52]  Keyes Jw,et al.  An Evaluation of Lung Uptake of Colloid During Liver Imaging , 1973 .

[53]  S. A. Rabinowitz,et al.  99mTc red blood cell scintigraphy in evaluating focal liver lesions. , 1984, AJR. American journal of roentgenology.

[54]  C. Degott,et al.  Liver adenomatosis. An entity distinct from liver adenoma? , 1985, Gastroenterology.

[55]  B J McNeil,et al.  Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison. , 1983, Radiology.

[56]  B B Gosink,et al.  Characteristic sonographic signs of hepatic fatty infiltration. , 1985, AJR. American journal of roentgenology.

[57]  S. Vallabhajosula,et al.  Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[58]  F. Jamar,et al.  Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[59]  E. Krenning,et al.  Somatostatin receptor imaging for neuroendocrine tumors , 2006, Pituitary.

[60]  A. Gimson,et al.  Focal nodular hyperplasia of the liver: results of treatment and options in management. , 1991, Gut.

[61]  J. Drouillard,et al.  Single photon emission computed tomography (SPECT), planar scintigraphy, and transmission computed tomography: a comparison of accuracy in diagnosing focal hepatic disease. , 1984, Radiology.

[62]  Y. Sugiyama,et al.  Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide. , 1996, The Journal of pharmacology and experimental therapeutics.

[63]  P. Sones,et al.  Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. , 1981, AJR. American journal of roentgenology.

[64]  L. Kvols,et al.  Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. , 1993, Radiology.

[65]  S. Othman,et al.  Features of hepatic cavernous hemangioma on planar and SPECT Tc-99m-labeled red blood cell scintigraphy. , 1999, Clinical nuclear medicine.

[66]  R. Mould An investigation of the variations in normal liver shape. , 1972, British Journal of Radiology.

[67]  M. Rehling,et al.  Somatostatin Receptor Scintigraphy , 1999 .

[68]  H. Meltzer,et al.  Hypercortisolism and depression. , 1985, The New England journal of medicine.

[69]  Rapid evaluation of hepatic size on radioisotope scan. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[70]  P. Angelberger,et al.  Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[71]  J. Drouillard,et al.  Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. , 1986, Radiology.

[72]  T. Waldmann,et al.  alpha-fetoprotein in noneoplastic hepatic disorders. , 1975, JAMA.

[73]  V. Sansalone,et al.  Surgical treatment of symptomatic giant hemangiomas of the liver. , 1992, Surgery, gynecology & obstetrics.

[74]  M. Lapiński,et al.  Focal nodular hyperplasia of the liver and intrahepatic hemorrhage in young women on oral contraceptives. , 1975, Annals of internal medicine.